DDIT3 and diffuse large B-cell lymphoma: We showed that CHOP treatment induced a potent inhibition of rRNA synthesis in DLBCL cell lines, this activity being mainly attributable to doxorubicin, which mirrored the effects of well-known RiBi inhibitors (such as Act D and CX-5461) on rRNA transcription.